In a volatile world with even shorter lead times and decreased buffers, shop-floor disruptions have more and more impact on plan adherence. Too much time spent on planning in inadequate systems/performance boards, high dependence on key individuals, constant need to follow-up with stakeholders on replanning impact and a loss of valuable production capacity due to inefficient planning systems and processes.
At Novo Nordisk we are in the process of addressing the gap to minimize capacity loss in a discrete productions with finite capacity and multiple shop-floor complications.
We invite you to come and hear how Novo Nordisk has addressed this challenge in our Biopharmaceutical Business.
Speaker: Jannik Magelund Madsen, Supply Chain Specialist @ Biopharm Business